NYSE
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Adtalem Global Education Inc. provides workforce solutions worldwide. The Medical and Healthcare segment offers degree and non-degree programs in the medical and healthcare postsecondary education industry. The Financial Services segment provides test preparation, certifications, conferences, seminars, memberships, and subscriptions to business professionals.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $899.2M | $1.4B | $1.5B | $1.6B | $1.8B |
| Gross profit | — | — | — | — | — |
| Operating income | $110.4M | $76.7M | $168.2M | $217.1M | $341.5M |
| Net income | $70.0M | $311.0M | $93.4M | $136.8M | $237.1M |
| Diluted EPS | $1.36 | $6.43 | $2.05 | $3.39 | $6.18 |
| Operating cash flow | $192.2M | $10.6M | $191.9M | $295.8M | $337.9M |
| Free cash flow | $152.3M | -$20.5M | $165.9M | $246.9M | $287.6M |
| Gross margin | — | — | — | — | — |
| Operating margin | 12.3% | 5.6% | 11.6% | 13.7% | 19.1% |
| Net margin | 7.8% | 22.5% | 6.4% | 8.6% | 13.3% |
| Line item | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $409.9M | $417.4M | $447.7M | $466.1M | $457.1M | $462.3M | $503.4M | $487.0M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $68.5M | $70.2M | $103.9M | $90.5M | $76.9M | $85.5M | $111.1M | $91.3M |
| Net income | $49.4M | $46.2M | $75.9M | $60.8M | $54.2M | $61.8M | $76.4M | $41.6M |
| Diluted EPS | $1.23 | $1.18 | $1.98 | $1.59 | $1.43 | $1.67 | $2.11 | $1.20 |
| Operating cash flow | $60.3M | $89.3M | -$19.0M | $207.9M | $59.7M | $130.5M | $29.7M | $186.2M |
| Free cash flow | $43.7M | $78.9M | -$29.7M | $197.7M | $40.7M | $114.5M | $15.1M | $165.9M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 16.7% | 16.8% | 23.2% | 19.4% | 16.8% | 18.5% | 22.1% | 18.8% |
| Net margin | 12.1% | 11.1% | 16.9% | 13.1% | 11.9% | 13.4% | 15.2% | 8.5% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-15 | Manning Amelia· President, Chamberlain Univ. | Award | 4,317 | $115.82 | $499,994.94 | filing |
| 2026-07-13 | Beard, Stephen W.· Chairman & CEO | Sale | 5,291 | $132.75 | $702,401.41 | filing |
| 2026-07-08 | BECK DOUGLAS G.· SVP, GC, Corp. Sec & ISS | Sale | 2,439 | $135.34 | $330,091.82 | filing |
| 2026-07-08 | Phelan Robert J.· Chief Financial Officer | Sale | 2,414 | $135.39 | $326,821.80 | filing |
| 2026-07-07 | Phelan Robert J.· Chief Financial Officer | Sale | 2,900 | $135.41 | $392,677.40 | filing |
| 2026-07-07 | BECK DOUGLAS G.· SVP, GC, Corp. Sec & ISS | Sale | 2,650 | $135.40 | $358,817.95 | filing |
| 2026-06-11 | Beard, Stephen W.· Chairman & CEO | Sale | 2,529 | $130.78 | $330,754.51 | filing |
| 2026-06-10 | Beard, Stephen W.· Chairman & CEO | Sale | 2,762 | $130.14 | $359,443.37 | filing |
| 2026-05-18 | Gangadharan Manjunath· VP, Chief Accounting Officer | Tax withholding | 426 | $127.85 | $54,464.10 | filing |
| 2026-05-08 | Beard, Stephen W.· Chairman & CEO | Sale | 15,874 | $131.25 | $2.1M | filing |
| 2026-05-08 | Phelan Robert J.· Chief Financial Officer | Sale | 10,000 | $126.21 | $1.3M | filing |
| 2026-05-08 | BECK DOUGLAS G.· SVP, GC, Corp. Sec & ISS | Sale | 9,615 | $127.03 | $1.2M | filing |
| 2026-05-08 | Cox Karen Sue· President, Chamberlain Univ. | Sale | 2,000 | $124.50 | $249,000.00 | filing |
| 2026-04-15 | Liles Scott· President, Medical and Vet | Tax withholding | 448 | $112.49 | $50,395.52 | filing |
| 2026-03-11 | MALAFRONTE MICHAEL W | Buy | 8,890 | $100.94 | $897,340.60 | filing |
| 2026-03-10 | MALAFRONTE MICHAEL W | Buy | 15,305 | $100.86 | $1.5M | filing |
| 2026-03-10 | MALAFRONTE MICHAEL W | Buy | 11,841 | $100.86 | $1.2M | filing |
| 2026-03-03 | MALAFRONTE MICHAEL W | Buy | 1,200 | $97.97 | $117,564.00 | filing |
| 2025-12-10 | Beard, Stephen W.· Chairman & CEO | Gift | 5,332 | $0.00 | $0.00 | filing |
| 2025-11-13 | Beard, Stephen W.· Chairman & CEO | Tax withholding | 9,204 | $96.26 | $885,977.04 | filing |
| 2025-11-13 | WARDELL LISA W | Tax withholding | 645 | $96.26 | $62,087.70 | filing |
| 2025-11-13 | Phelan Robert J.· Chief Financial Officer | Tax withholding | 623 | $96.26 | $59,969.98 | filing |
| 2025-11-13 | MALAFRONTE MICHAEL W | Tax withholding | 526 | $96.26 | $50,632.76 | filing |
| 2025-11-13 | Betz Michael· Pres. Walden University & CDO | Tax withholding | 441 | $96.26 | $42,450.66 | filing |
| 2025-11-13 | Kiser Georgette D. | Tax withholding | 425 | $96.26 | $40,910.50 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.